Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma In vitro and In vivo
Authors:
Open Access
- 15 March 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (6) , 1840-1848
Abstract
Purpose: Vitamin E succinate (α-TOS) inhibits the growth of cancer cells without unacceptable side effects. Therefore, the mechanisms associated with the anticancer action of α-TOS, including ceramide-mediated apoptosis, were investigated using head and neck squamous cell carcinoma (HNSCC) in vitro and in vivo. Experimental Design: Five different human HNSCC cell lines (JHU-011, JHU-013, JHU-019, JHU-022, and JHU-029) were treated with α-TOS, and its effects on cell proliferation, cell cycle progression, ceramide-mediated apoptosis, and ceramide metabolism were evaluated. The anticancer effect of α-TOS was also examined on JHU-022 solid tumor xenograft growth in immunodeficient mice. Results: α-TOS inhibited the growth of all the HNSCC cell lines in vitro in a dose- and time-dependent manner. Thus, JHU-013 and JHU-022 cell lines were more sensitive to α-TOS than the other cell lines. Cellular levels of ceramide, sphingomyelinase activity, caspase-3, and p53 were elevated with increasing time of exposure to α-TOS. The degradation of poly(ADP-ribose) polymerase protein in JHU-022 cells treated with α-TOS provided evidence for apoptosis. The amounts of nuclear factor κB, Bcl-2, and Bcl-XL proteins were reduced in the cells treated with α-TOS for 6 hours. The levels of caspase-9, murine double minute-2, and IκB-α proteins were unchanged after α-TOS treatment. I.p. administration of α-TOS slowed tumor growth in immunodeficient mice. Conclusions: α-TOS showed promising anticancer effects to inhibit HNSCC growth and viability in vivo and in vitro. The induction of enzymes involved in ceramide metabolism by α-TOS suggests that ceramide-mediated apoptosis may expand therapeutic strategies in the treatment of carcinoma.Keywords
This publication has 40 references indexed in Scilit:
- A Peptide Conjugate of Vitamin E Succinate Targets Breast Cancer Cells with High ErbB2 ExpressionCancer Research, 2007
- Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move ForwardClinical Cancer Research, 2006
- α-Tocopheryl Succinate Induces Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 FunctionJournal of Biological Chemistry, 2006
- Apoptosis effector mechanisms: A requiem performed in different keysApoptosis, 2006
- BCL2 Family of Apoptosis-Related Genes: Functions and Clinical Implications in CancerCritical Reviews in Clinical Laboratory Sciences, 2006
- α-Tocopheryl Succinate Inhibits Malignant Mesothelioma byDisrupting the Fibroblast Growth Factor Autocrine LoopJournal of Biological Chemistry, 2005
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathwayJournal of Cell Biology, 2004
- α-Tocopheryl succinate epitomizes a compound with a shift in biological activity due to pro-vitamin-to-vitamin conversionBiochemical and Biophysical Research Communications, 2002
- Ascorbate and α-Tocopherol Prevent Apoptosis Induced by Serum Removal Independent of Bcl-2Archives of Biochemistry and Biophysics, 1997